Figure 2
From: Improving treatment outcome assessment in a mouse tuberculosis model
Visual predictive check (VPC) of the final model for each regimen. (A) rifapentine, pyrazinamide, isoniazid and ethambutol (RpZHE), (B) rifampicin, pyrazinamide, moxifloxacin and ethambutol (RZME) and (C) rifampicin, pyrazinamide, moxifloxacin and isoniazid (RZMH). The open circles connected by the solid black lines are the observed probabilities of cure following different treatment lengths and the shaded areas are the 95% non-parametric confidence interval of the predicted cure rates following different treatment lengths.
